Geroprotective and Anticarcinogenic Activity Lifetime Murine Studies Long-term studies in mice demonstrated that DSIP administration over a lifetime decreased total spontaneous tumour incidence 2.6-fold compared to untreated controls, slowed age-related switching-off of oestrous function, decreased the frequency of chromosome aberrations in bone marrow cells by 22.6%, and increased maximum lifespan by 24.1% compared to control groups a multi-parameter geroprotective profile that is among the most striking reported for any short regulatory peptide, and that has generated sustained interest in the DSIP analogue research field
ULTIMA LABS Premium Research Grade Peptides Secure Payments Legal Privacy Policy Terms & Conditions Returns Policy Disclaimer Policy Support Shipping Policy FAQ Contact Us Company About Us Research Vote Affiliates Wholesale ULTIMA RESEARCH TECHNOLOGIES CORPORATION LTD 2025
Achieve Your Goals with Advanced Laser Treatments Lasers are able to penetrate the skin without breaking it, reaching deep beneath the surface to activate the bodys own regenerative abilities
Empagliflozin attenuates renal tubular ferroptosis in preeclampsia via tazarotene-induced gene 1
Discussion Chronic diabetic wounds represent a huge healthcare challenge, necessitating sustained and synchronized regulation of the wound microenvironment simultaneously with tissue reconstruction processes
Contaminated solutions accelerate degradation